Preclinical efficacy of endoglin-targeting antibody-drug conjugates for the treatment of Ewing sarcoma.

Por Puerto-Camacho, Pilar, Amaral, Ana Teresa, Lamhamedi-Cherradi, Salah-Eddine, Menegaz, Brian A., Castillo-Ecija, Helena, Ordóñez, José Luis, Domínguez, Saioa, Jordan-Perez, Carmen, Diaz-Martin, Juan, Romero-Pérez, Laura, Lopez-Alvarez, Maria, Civantos-Jubera, Gema, Robles-Frías, María José, Biscuola, Michele, Ferrer, Cristina, Mora, Jaume, Cuglievan, Branko, Schadler, Keri, Seifert, Oliver, Kontermann, Roland, Pfizenmaier, Klaus, Simón, Laureano, Fabre, Myriam, Carcaboso, Ángel M., Ludwig, Joseph A., de Álava, Enrique
Publicado no Clin Cancer Res (2018)